In agreement with our results, Herder et al. reported data from 236 T2D patients, 242 subjects with impaired glucose tolerance, and 244 normoglycemic controls indicating that the MCP-1 levels were not associated with impaired glucose tolerance, T2D or several parameters of obesity [28]. This evidence concerns the gene CCL2 and obesity disorder.